Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRO Concept

1,677.91
-11.8744-0.70%
Number of Gainers:- -
Number of Losers:2
Number of Flat:1
PE:- -
High:1,700.36
Open:1,689.10
Low:1,645.47
Close:1,689.78
Loading ...

IQVIA Holdings Inc. Officer Eric Sherbet Reports Disposal of Common Shares

Reuters
·
4 hours ago

Biogen receives positive CHMP opinion for ZURZUVAE in PPD

TIPRANKS
·
Yesterday

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression

GlobeNewswire
·
Yesterday

Charles River Laboratories Shares up 7.6% After Larger Rival West Pharmaceutical Raises Annual Profit Forecast

THOMSON REUTERS
·
24 Jul

IQVIA Holdings Inc : Argus Research Raises Target Price to $230 From $180

THOMSON REUTERS
·
24 Jul

Evercore ISI Remains a Buy on IQVIA Holdings (IQV)

TIPRANKS
·
23 Jul

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Reuters
·
23 Jul

Sector Update: Health Care Stocks Rise Tuesday Afternoon

MT Newswires Live
·
23 Jul

Iqvia rises 16.3%

TIPRANKS
·
22 Jul

Iqvia Shares Climb After Tightening of 2025 Guidance Ranges

Dow Jones
·
22 Jul

Charles River Laboratories and Elly's Team Secure FDA Approval for Pioneering Gene Therapy Targeting Rare Neurodevelopmental Disorder

Reuters
·
22 Jul

Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

GlobeNewswire
·
22 Jul

At US$159, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?

Simply Wall St.
·
17 Jul

FDA Lifts Veil on Drug Approval Process: Four Chinese Pharma Rejections Expose Overseas Expansion Challenges

Market Watcher
·
16 Jul

Charles River Laboratories International Inc. Announces Second-Quarter 2025 Financial Results Release

Reuters
·
15 Jul

Morning Movers: Capricor Therapeutics plunges following CRL from FDA

TIPRANKS
·
11 Jul

Video: Capricor plunges after CRL, Performance Foods up after seeing interest

TIPRANKS
·
11 Jul

Capricor Receives FDA CRL for Deramiocel BLA

TIPRANKS
·
11 Jul

Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray

GlobeNewswire
·
11 Jul